Predictions
Bluebird Bio Inc.
Start price
Target price
Perf. (%)
€6.22
06.02.22
06.02.22
-
06.02.23
06.02.23
-15.28%
20.02.22
20.02.22
Risky Investment
Molecular Templates Inc.
Start price
Target price
Perf. (%)
€2.53
06.02.22
06.02.22
-
06.02.23
06.02.23
-8.76%
20.02.22
20.02.22
Could be very worthwhile Investment >20% year
Valneva SE
Start price
Target price
Perf. (%)
€15.03
05.02.22
05.02.22
€20.00
05.02.23
05.02.23
-57.41%
06.02.23
06.02.23
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Good culture
Could be very worthwhile Investment >20% year
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€0.53
05.02.22
05.02.22
-
05.02.23
05.02.23
-
06.02.23
06.02.23
Bellicum Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.23
05.02.22
05.02.22
€3.00
05.02.23
05.02.23
21.14%
19.02.22
19.02.22
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€5.75
05.02.22
05.02.22
€10.00
05.02.23
05.02.23
21.74%
19.02.22
19.02.22
Vanda Pharmaceuticals
Start price
Target price
Perf. (%)
€11.10
05.02.22
05.02.22
€20.00
05.02.23
05.02.23
5.41%
19.02.22
19.02.22
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€1.68
05.02.22
05.02.22
€2.00
05.02.23
05.02.23
10.12%
19.02.22
19.02.22
BiondVax Pharmaceuticals Ltd ADR
Start price
Target price
Perf. (%)
€0.40
04.02.22
04.02.22
-
-
06.02.22
06.02.22
Risky Investment
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€56.78
04.02.22
04.02.22
€46.00
04.02.23
04.02.23
18.67%
13.10.22
13.10.22
Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Theranexus
Start price
Target price
Perf. (%)
€3.18
04.02.22
04.02.22
€36.00
04.02.23
04.02.23
-41.98%
05.02.23
05.02.23
Could be worthwhile Investment >10% per year
Sangamo Therapeutics Inc.
Start price
Target price
Perf. (%)
€5.04
02.02.22
02.02.22
-
02.02.23
02.02.23
-4.33%
06.02.22
06.02.22
Risky Investment
Clovis Oncology Inc.
Start price
Target price
Perf. (%)
€1.66
02.02.22
02.02.22
-
02.02.23
02.02.23
-3.83%
06.02.22
06.02.22
Risky Investment
Nektar Therapeutics
Start price
Target price
Perf. (%)
€9.30
02.02.22
02.02.22
-
02.02.23
02.02.23
-2.26%
06.02.22
06.02.22
Risky Investment
Novavax Inc.
Start price
Target price
Perf. (%)
€87.29
01.02.22
01.02.22
-
01.02.23
01.02.23
-88.23%
02.02.23
02.02.23
Could be worthwhile Investment >10% per year
Fair valuation
Revenue growth >5% per year expected
Standard Investments for future growth